@article{ref1,
title="Inhibition is associated with metabolic syndrome and depression through inflammation",
journal="Stress and Health",
year="2018",
author="Murdock, Kyle W. and LeRoy, Angie S. and Fagundes, Christopher P.",
volume="34",
number="3",
pages="457-461",
abstract="Inhibition is the ability to stop one's self from responding, or paying attention, to tempting/distracting stimuli or thoughts. Those with poor inhibition are at greater risk of depression and a variety of diseases of older adulthood than those with better inhibition. Inflammation may be a mechanism underlying these links. A total of 840 participants from the Midlife in the United States study completed a neuropsychological measure of inhibition, a self-report measure of depressive symptoms, and a blood draw. <br><br>RESULTS indicated that poor inhibition was associated with high interleukin-6 (IL-6). Inhibition was indirectly associated with metabolic syndrome incidence and depressive symptoms through IL-6. <br><br>FINDINGS suggest that IL-6 may be a mechanism linking inhibition with metabolic syndrome and depression.<br><br>Copyright © 2018 John Wiley & Sons, Ltd.<p /> <p>Language: en</p>",
language="en",
issn="1532-3005",
doi="10.1002/smi.2808",
url="http://dx.doi.org/10.1002/smi.2808"
}